That being said, liraglutide was used successfully in the small trial at Penn for opioid cravings, discussed above, and as a generic it may be a more affordable option in some situations
In 2014, Novos Saxenda (liraglutide) became the first GLP-1 agonist approved for obesity
Ask where your peptides come from
The latter issue has made the WHO not to recommend the use of GLP-1RAs in their most recent set of recommendations (122)
Physical interventions: We encourage our patients to seek therapy in various forms, such as chiropractic adjustments, massage, ultrasound, physical therapy, shockwave therapy, cold laser or acupuncture, to name a few
Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, et al